MENU
GILD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Gilead Sciences (GILD) Ownership - Who owns Gilead Sciences?
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
333 Lakeside Drive
Phone
+1 650 574-3000
Employees
18000
Web
https://www.gilead.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
146.39B
P/E Ratio
23.41
Total Cash
5.21B
Projected Growth
0.24
Total Debt
24.95B
Revenue
28.86B
Risk (Beta)
0.44
Dividend Yield
0.03
Total Cash/Share
4.20
Total Debt/Equity
71.31
Revenue/Share
22.91 USD as % of share price
Fundamentals
GILD
Capitalization
146B
P/E Ratio
23.41
Risk (Beta)
0.44
Dividend Yield
0.03
Total Cash
5.21B
Total Cash/Share
4.20
Total Debt
24.9B
Total Debt/Equity
71.31
Projected Growth (PEG Ratio)
0.24
Revenue/Share (as % of the share price)
22.91%
Revenue
28.9B
ROE
N/A
Book Value
19.7B
P/B Ratio
7.44
Cash Flow
N/A
Earnings
5.06
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1M
Current Ratio
1.32
Current Revenue Per Employee
402329.53
Dividends Per Share - Security
0.79
EBITDA
11B
Float
N/A
Float - Current
N/A
Gross Income Margin
78.80
Revenue To Assets
11.55
Shares Held By Institutions
328B
Shares Outstanding - Current
1.24B
Total Liabilities
36.1B
Total Volume MTD
N/A
Value
1
Gain YTD
29.535
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GILD showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a developer of therapeutic products and treatments for life threatening diseases
Industry PharmaceuticalsMajor
Profile
Fundamentals
Details
Industry
Biotechnology
Address
333 Lakeside Drive
Phone
+1 650 574-3000
Employees
18000
Web
https://www.gilead.com